About Kent Lewandrowski, MD

Kent Lewandrowski, MD is the Associate Chief for Laboratory and Molecular Medicine at the Massachusetts General Hospital Pathology Service. He is a Professor of Pathology at Harvard Medical School, with research interests in pancreatic pathology and the evaluation of point-of-care technologies. Dr. Lewandrowski is a member of the leadership team of Mass General Brigham Personalized Medicine. Read more about Dr. Lewandrowski's contributions to operations improvement, regulatory compliance, strategic planning, and quality improvement. He has published several studies on the impact of rapid point-of-care testing on outcomes in the emergency department, particularly in relation to reducing emergency room length-of-stay and reducing unnecessary hospital admissions. He is editor in chief of the medical journal  "Point of Care: The Journal of Near Patient Testing Technology". Dr. Lewandrowski was trained in anatomic and clinical pathology at the Massachusetts General Hospital and has been on the staff of the department of Pathology since 1991.

Departments, Centers, & Programs:

Clinical Interests:

Treats:

Locations

Mass General Pathology
55 Fruit St.
Boston, MA 02114
Phone: 617-643-0800

Medical Education

  • MD, UMASS Medical School

American Board Certifications

  • Anatomic Pathology and Clinical Pathology, American Board of Pathology

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research

Dr. Lewandrowski's research interests include point-of-care diagnostics, and serum cardiac markers. He also studies the pathology of the pancreas, including chemical and histopathologic features of pancreatic neoplasms and the pathology of acute experimental pancreatitis. For more information about research concepts, co-authors, and to see a timeline, visit Dr. Lewandrowski's profile at the Harvard Clinical and Translational Science Center. 

Publications

Reviews: Comments and Ratings